Enliven Therapeutics
ELVN
#4380
Rank
C$3.25 B
Marketcap
C$54.41
Share price
10.58%
Change (1 day)
78.81%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of December 2025 : C$0.55 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is C$0.55 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2025)

Total debt by year

Year Total debt Change
2025-12-31C$0.54 M
2024-12-31N/A-100%
2023-12-31C$0.44 M1.38%
2022-12-31C$0.43 M116.3%
2021-12-31C$0.2 M51.35%
2020-12-31C$0.13 M